heart failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced cardiac output - Heart failure often arises from the heart's inability to pump blood efficiently, leading to decreased cardiac output. This is commonly due to weakened heart muscle (systolic dysfunction) or stiffened heart muscle (diastolic dysfunction), impairing the heart's ability to fill and eject blood efficiently.

• Secondary mechanism: Neurohormonal activation - The body compensates for reduced cardiac output by activating the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system. This leads to vasoconstriction, increased heart rate, and fluid retention, initially supporting circulation but eventually worsening heart failure.

• Key complication: Fluid overload - As a result of neurohormonal activation, excess fluid accumulates in tissues, causing symptoms like edema and pulmonary congestion, which further aggravates cardiac workload and symptom severity.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin, Furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath

• Key symptoms: Fatigue, peripheral edema, orthopnea, decreased exercise tolerance

• Vital signs: Blood pressure 145/85 mmHg, heart rate 110 bpm, respiratory rate 24 breaths/min, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

Three days into hospitalization, the patient's clinical status has changed, indicating the development of new complications. Despite initial management efforts, including diuretics and oxygen therapy, his shortness of breath has worsened, and supplemental oxygen requirements have increased. The patient now requires 3 liters per minute of oxygen via nasal cannula to maintain oxygen saturation at 94%. Additionally, his peripheral edema has become more pronounced, extending from the ankles to the knees. He reports increased difficulty in breathing while lying flat, necessitating elevation of the head of the bed to alleviate orthopnea.

Recent laboratory results reveal a rise in B-type natriuretic peptide (BNP) levels to 850 pg/mL, suggesting worsening heart failure. Serum creatinine has increased to 1.8 mg/dL from a baseline of 1.2 mg/dL, indicating potential renal impairment due to either decreased perfusion or diuretic therapy. Electrolyte imbalances are also noted, with a potassium level of 3.2 mEq/L, raising concerns about the risk of cardiac arrhythmias. An echocardiogram performed yesterday shows an ejection fraction of 35%, confirming reduced systolic function.

These developments necessitate a reassessment of the current treatment plan. The healthcare team must consider optimizing diuretic therapy while carefully monitoring renal function and electrolytes. Given the worsening of heart failure symptoms and evidence of renal involvement, adjusting the dosages of current medications or adding aldosterone antagonists may be warranted. Additionally, exploring the potential for advanced heart failure therapies, such as inotropic support or referral to a heart failure specialist, should be considered to manage this patient's increasingly complex clinical picture effectively.

Section 2

The patient's clinical status continues to evolve, marked by the emergence of new complications that demand immediate attention. On the morning of the fourth day of hospitalization, the patient exhibits signs of acute respiratory distress, with respiratory rate climbing to 28 breaths per minute. His blood pressure has dropped to 98/60 mmHg, and heart rate has increased to 112 beats per minute, indicating a compensatory response to decreased cardiac output. Auscultation of the lungs reveals bilateral crackles extending to the mid-lung fields, suggesting pulmonary congestion. The patient is visibly anxious, struggling to complete sentences due to dyspnea, and requires an increase in supplemental oxygen to 4 liters per minute to maintain an oxygen saturation of 92%.

In light of these changes, the interdisciplinary team conducts a thorough reassessment. Arterial blood gas analysis shows a pH of 7.32, partial pressure of carbon dioxide (PaCO2) at 48 mmHg, and partial pressure of oxygen (PaO2) at 58 mmHg, indicative of respiratory acidosis and hypoxemia. A repeat echocardiogram indicates further decline in heart function, with an ejection fraction now at 30%. These findings point to a progression of heart failure with acute decompensation, likely exacerbated by renal dysfunction and electrolyte imbalances.

The team initiates a more aggressive management approach, including consideration for intravenous inotropic support to enhance cardiac contractility and improve perfusion. To address the worsening edema and electrolyte disturbances, the diuretic regimen is re-evaluated, with plans to adjust dosing and introduce potassium-sparing diuretics such as spironolactone. A cardiology consultation is requested to explore advanced therapies, including potential candidacy for mechanical circulatory support or heart transplantation. The patient is closely monitored, with frequent reassessment of vital signs, renal function, and electrolytes, as the team endeavors to stabilize his condition and prevent further deterioration.

Section 3

Throughout the day, the interdisciplinary team focuses on the patient’s response to the newly implemented interventions. Initially, there is a slight improvement in the patient’s hemodynamic status. With the administration of intravenous inotropic support, the patient’s heart rate stabilizes at around 104 beats per minute, and his blood pressure rises modestly to 105/65 mmHg. Respiratory rate decreases slightly to 26 breaths per minute, and the patient reports feeling marginally less short of breath. Supplemental oxygen is maintained at 4 liters per minute, and his oxygen saturation improves to 94%.

Despite these encouraging early responses, the patient begins to exhibit signs of new complications by the end of the day. Laboratory results reveal a concerning increase in serum creatinine to 2.1 mg/dL, indicating worsening renal function, likely a consequence of both diuretic therapy and decreased renal perfusion. Electrolyte analysis shows a serum potassium level of 3.2 mEq/L, highlighting a potential risk for arrhythmias due to hypokalemia. The patient also reports new-onset mild chest discomfort, prompting further investigation to rule out ischemic changes or arrhythmogenic events.

The team remains vigilant, understanding the delicate balance required in managing heart failure with concurrent renal impairment. A decision is made to adjust the diuretic regimen, reducing the dose of loop diuretics and cautiously increasing spironolactone to address the low potassium levels. Continuous monitoring is emphasized, with plans to reassess renal function and electrolytes within the next few hours. The cardiology team is consulted to evaluate the chest discomfort, and plans for telemetry monitoring are reinforced to detect any cardiac arrhythmias. The patient’s journey highlights the complexity of heart failure management and the need for meticulous clinical reasoning and timely interventions.

Section 4

As the evening progresses, the patient begins to exhibit further changes in his clinical status. The nursing team notes an increase in his respiratory rate to 30 breaths per minute, and his oxygen saturation has decreased slightly to 91% despite maintaining supplemental oxygen. He appears more anxious and agitated, expressing an increased sense of breathlessness than earlier in the day. These changes prompt an immediate reassessment of his respiratory and cardiovascular systems. On auscultation, there are diffuse crackles present bilaterally, suggesting worsening pulmonary congestion. Additionally, the patient’s jugular venous distention appears more pronounced, indicating elevated central venous pressure.

In response to these developments, the interdisciplinary team conducts a thorough review of the patient's latest laboratory results. A repeat serum creatinine level shows a further increase to 2.4 mg/dL, confirming the progression of renal impairment. Concurrently, the potassium level has improved marginally to 3.5 mEq/L following the adjusted diuretic therapy, but remains on the lower side. An urgent chest X-ray is performed, revealing increased pulmonary vascular markings and interstitial edema, consistent with acute decompensated heart failure.

The team deliberates on the next steps, balancing the need to alleviate fluid overload while minimizing further renal compromise. A decision is made to initiate a low-dose intravenous nitroglycerin infusion to reduce preload and afterload, aiming to improve cardiac output and respiratory status without exacerbating hypotension. The patient is repositioned with the head of the bed elevated to facilitate breathing and reduce venous return. Continuous telemetry monitoring is maintained to detect any arrhythmias, and plans are set for close follow-up of renal function and electrolytes. This stage of the patient's journey underscores the intricate and dynamic nature of managing heart failure with concurrent renal challenges, requiring ongoing assessment and adjustment of the therapeutic plan.

Section 5

As the night progresses, the nursing team closely monitors the patient's response to the interventions. Initially, there is a modest improvement in his respiratory effort, with his respiratory rate decreasing to 26 breaths per minute. His oxygen saturation stabilizes at 93% with supplemental oxygen, offering a brief reprieve from his earlier distress. The patient reports feeling slightly less breathless, and his anxiety diminishes as he becomes more comfortable with the head of the bed elevated. Despite this, the team remains vigilant for any signs of deterioration or new complications.

In the early hours of the morning, the patient begins exhibiting new symptoms. He develops a persistent, non-productive cough, and his heart rate increases to 110 beats per minute. His blood pressure has decreased slightly to 98/58 mmHg, raising concerns about potential hypotension due to the nitroglycerin infusion. Physical examination reveals increased diaphoresis and a slight temperature elevation to 37.8°C (100°F), suggesting the possibility of an underlying infection or inflammatory process. Given these changes, the team considers the potential for sepsis or other complications that could exacerbate his heart failure.

The medical team decides to conduct additional diagnostic tests to rule out infection and assess any further cardiac complications. Blood cultures are obtained, and a complete blood count is performed, revealing a white blood cell count of 14,000/mm³, indicating a possible infectious process. A repeat chest X-ray is ordered to evaluate for any signs of pneumonia or other pulmonary complications. Meanwhile, the nitroglycerin infusion is carefully titrated to balance the need for preload reduction with maintaining adequate blood pressure. These developments highlight the complexity of managing this patient's condition, as the team must navigate the interplay between his heart failure, potential infection, and renal compromise.